SECsense Logo

Carisma Therapeutics Inc. 8-K Filing: Key Insights as of December 24, 2024

$CARM
Form 8-K
Filed on: 2024-12-26
Source
Carisma Therapeutics Inc. 8-K Filing: Key Insights as of December 24, 2024

Based on the provided section of the financial report, here are the key points extracted:

  1. Entity Information:
  • Company Name: Carisma Therapeutics Inc.
  • CIK (Central Index Key): 0001485003
  • SEC File Number: 001-36296
  • EIN (Employer Identification Number): 26-2025616
  • Address: 3675 Market Street, Suite 401, Philadelphia, PA 19104
  • Contact Number: 267-491-6422
  1. Filing Type:
  • Form: 8-K
  • Filing Date: December 24, 2024
  1. Financial Context:
  • Reporting Period: The report is dated as of December 24, 2024, indicating it captures information as of that specific date.
  • Currency: The amounts reported are in U.S. Dollars (USD).
  • Stock Information: The company has common stock with a par value of $0.001 per share.
  • Ticker Symbol: CARM (listed on NASDAQ).
  1. Units of Measure:
  • Financial amounts are measured in USD.
  • Share counts are measured in shares.
  1. Additional Notes:
  • The document is structured in XML format, specifically using the XBRL (eXtensible Business Reporting Language) format, which is standard for SEC filings.

Overall, this report provides a snapshot of Carisma Therapeutics Inc. as of December 24, 2024, indicating it is a public company listed on NASDAQ with common stock issued at a nominal par value. The filing type (8-K) suggests that it is likely to report significant events or changes that are necessary for investors to know.